Pan-Tumor IHC Screen Suggests FAP Target is Attractive for PTRT
A pan-tumor IHC screen identified high fibroblast activating protein (FAP) expression in multiple tumor types that correlated with in vitro
Read moreA pan-tumor IHC screen identified high fibroblast activating protein (FAP) expression in multiple tumor types that correlated with in vitro
Read moreTezepelumab, developed by AstraZeneca in collaboration with Amgen, has been granted Orphan Drug Designation (ODD) in the US FDA for
Read moreThe World Health Organization on Wednesday endorsed the groundbreaking GlaxoSmithKline Malaria vaccine for children at risk reinvigorating the fight against
Read moreInterim Analysis of Phase 3 Study shows Merck and Ridgeback’s investigational oral antiviral Molnupiravir has reduced the risk of hospitalization
Read moreKite Pharma, a Gilead Company, announced on Friday that the U.S. FDA has granted approval for CAR T-cell therapy Tecartus®
Read morePfizer has reported that the Japanese Ministry of Health, Labour and Welfare (MHLW) authorized CIBINQO® (abrocitinib), a novel therapy for
Read morePfizer and BioNTech reported that data from their COVID-19 vaccine Phase 2/3 study in children aged 5 to 12 years
Read moreTakeda and JCR Pharmaceuticals announced today a geo-based exclusive collaboration and license agreement to commercialize JR-141 (INN: pabinafusp alfa), an
Read moreNHS Foundation Trust Professionals are choosing Tinytag data loggers to monitor vaccine fridges and cool boxes to help verify that
Read moreGenmab A/S and Seagen Inc. revealed that the first and only approved antibody-drug conjugate (ADC) known as TIVDAK™ (tisotumab vedotin-tftv),
Read more